‘Progressive diabetic nephropathy. How useful is microalbuminuria

Slides:

Advertisements

Similar presentations

Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function Featured Article: Elif I. Ekinci, P.H.D.,

Advertisements

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto

Frederik Persson, Peter Rossing Kidney International Supplements

Viper venom for diabetic nephropathy

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Blaithin A. McMahon, Patrick Thomas Murray Kidney International

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Volume 67, Issue 6, Pages (June 2005)

Volume 85, Issue 2, Pages (January 2014)

Viper venom for diabetic nephropathy

Prehypertension and chronic kidney disease: the ox or the plow?

Volume 80, Issue 10, Pages (November 2011)

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

John P. Middleton, Patrick H. Pun Kidney International

Volume 81, Issue 7, Pages (April 2012)

Chapter 3: Management of progression and complications of CKD

Volume 77, Issue 8, Pages (April 2010)

Volume 77, Issue 1, Pages 5-6 (January 2010)

Methotrexate in the urine

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Volume 74, Issue 3, Pages (August 2008)

Targets to retard the progression of diabetic nephropathy

Manjula Kurella Tamura, Kristine Yaffe Kidney International

Renal risk scores: Progress and prospects

Volume 63, Issue 1, Pages (January 2003)

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Predicting an allograft's fate

Prediabetes as a Precursor to Diabetic Kidney Disease

Polyunsaturated Fatty Acids and Kidney Disease

U-shaped effect of eGFR and mortality

Volume 81, Issue 5, Pages (March 2012)

David M. Charytan, John P. Forman Kidney International

A physician's perseverance uncovers problems in a key nephrology study

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto

Impact of gender on the renal response to angiotensin II

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

Calcium sensing in podocytes

Methods for guideline development

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

IgA nephropathy at two score and one

Volume 67, Issue 4, Pages (April 2005)

Volume 66, Issue 3, Pages (September 2004)

Nephrology Crossword: Glomerulonephritis

Volume 60, Issue 1, Pages (July 2001)

Volume 80, Issue 3, Pages (August 2011)

Volume 79, Issue 4, Pages (February 2011)

Volume 60, Issue 1, Pages (July 2001)

Volume 80, Issue 10, Pages (November 2011)

Volume 77, Issue 1, Pages (January 2010)

Volume 72, Issue 11, Pages (December 2007)

Inhibition of the renin–angiotensin system: is more better?

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 56, Issue 4, Pages (October 1999)

Volume 58, Issue 2, Pages (August 2000)

Membranous nephropathy: recent travels and new roads ahead

Adiponectin: good, bad, or just plain ugly?

Dana V. Rizk, David G. Warnock Kidney International

Volume 55, Issue 3, Pages (March 1999)

Volume 53, Issue 5, Pages (May 1998)

Volume 80, Issue 9, Pages (November 2011)

Volume 57, Issue 2, Pages (October 2000)

Volume 75, Issue 8, Pages (April 2009)

Kidney and hypertension

The Ebf1 knockout mouse and glomerular maturation

Volume 79, Issue 10, Pages (May 2011)

Presentation transcript:

‘Progressive diabetic nephropathy. How useful is microalbuminuria ‘Progressive diabetic nephropathy. How useful is microalbuminuria?: contra’ Richard J. MacIsaac, Elif I. Ekinci, G. Jerums Kidney International Volume 86, Issue 1, Pages 50-57 (July 2014) DOI: 10.1038/ki.2014.98 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Modern rates of progression versus remission/regression of microalbuminuria. *Regression. RAS, renin-angiotensin system. Kidney International 2014 86, 50-57DOI: (10.1038/ki.2014.98) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Prevalence of low glomerular filtration rate (GFR) and normoalbuminuria. RAS, renin-angiotensin system. Kidney International 2014 86, 50-57DOI: (10.1038/ki.2014.98) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between initial change in albumin excretion rate (AER) and overall change in glomerular filtration rate (GFR) per year in type 1 diabetes. (a) Mean data from 23 study groups in nine studies of type 1 diabetes and early diabetic nephropathy are shown. (b) Mean data from 10 study groups in five studies of type 1 diabetes and late diabetic nephropathy are shown. Reproduced with permission from Jerums et al.58 Kidney International 2014 86, 50-57DOI: (10.1038/ki.2014.98) Copyright © 2014 International Society of Nephrology Terms and Conditions